Annexon Reports First Quarter 2026 Financial Results, Portfolio Progress and Key Anticipated Milestones
Annexon reported a Q1 net loss of $44.1 million, or $0.23 per share, an improvement from the $54.4 million loss in the prior-year period, driven largely by a 26% decrease in R&D expenses to $35.8 million. The company maintained a strong balance sheet with $225 million in cash and investments, providing an anticipated operational runway into the second half of 2027.
Key figures
- Guidance
- Topline Phase 3 ARCHER II data expected Q4 2026; BLA submission for tanruprubart expected 2026; POC data for ANX1502 expected 2026
- Runway
- Second half of 2027
- Net loss
- 44.1
- Rd expenses
- 35.8
- Cash and investments
- $225.0 million
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.